SBC Medical Group (SBC) Stock Price, News & Analysis

Company Overview

SBC Medical Group, Inc. is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services. SBC Medical Group leverages proprietary software platforms and workflow automation tools to manage patient registration, claims submission and payment reconciliation. By integrating clinical documentation improvement and audit support, the company aims to reduce denials, accelerate cash collections and ensure adherence to regulatory requirements.

Operating across the United States, SBC Medical Group partners with a range of specialties including diagnostic imaging, physical therapy, laboratory services and radiation therapy providers. The company’s end-to-end service model is tailored to the specific needs of each client, enabling faster onboarding of new sites and scalability as practices expand. SBC Medical Group’s leadership team brings experience from healthcare operations, technology development and financial services to drive growth and operational excellence.

Key Stats

• Today's Range: $4.21 to $4.39
• 50-Day Range: $2.93 to $4.28
• 52-Week Range: $2.78 to $5.07
• Volume: 205,690 shs
• Average Volume: 191,362 shs
• Market Capitalization: $440.20 million
• P/E Ratio: 9.11
• Dividend Yield: N/A
• Price Target: $8.50
• Consensus Rating: Hold

SBC Medical Group Stock Analysis - MarketRank™

SBC Medical Group scored higher than 83% of companies evaluated by MarketBeat, and ranked 93rd out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

SBC Medical Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

SBC Medical Group has a consensus price target of $8.50, representing about 98.6% upside from its current price of $4.28.

Amount of Analyst Coverage

SBC Medical Group has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 18.18%

Earnings Growth

Earnings for SBC Medical Group are expected to grow by 18.18% in the coming year, from $0.44 to $0.52 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of SBC Medical Group is 9.11, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.20.

Price to Earnings Ratio vs. Sector

The P/E ratio of SBC Medical Group is 9.11, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.59.

Price to Book Value per Share Ratio

SBC Medical Group has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.58% of the float of SBC Medical Group has been sold short.

Short Interest Ratio / Days to Cover

SBC Medical Group has a short interest ratio ("days to cover") of 4.65.

Change versus previous month

Short interest in SBC Medical Group has recently decreased by 17.13%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SBC Medical Group does not currently pay a dividend.

Dividend Growth

SBC Medical Group does not have a long track record of dividend growth.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: 0.62

News Sentiment

SBC Medical Group has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for SBC Medical Group this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for SBC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SBC Medical Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

81.70% of the stock of SBC Medical Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

60.82% of the stock of SBC Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 9/03/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:SBC
• Previous Symbol: NASDAQ:SBC
• CIK: 1930313
• Web: sbc-holdings.com
• Phone: 808-892-6611
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for SBC Medical Group: $8.50
• High Price Target: $9.00
• Low Price Target: $8.00
• Potential Upside/Downside: +98.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.47
• Trailing P/E Ratio: 9.11
• Forward P/E Ratio: 9.73
• P/E Growth: N/A
• Net Income: $50.99 million
• Net Margins: 27.99%
• Pretax Margin: 43.09%
• Return on Equity: 18.47%
• Return on Assets: 13.10%

Debt

• Debt-to-Equity Ratio: 0.09
• Current Ratio: 3.31
• Quick Ratio: 3.27

Sales & Book Value

• Annual Sales: $173.61 million
• Price / Sales: 2.54
• Cash Flow: $0.53 per share
• Price / Cash Flow: 8.08
• Book Value: $2.72 per share
• Price / Book: 1.57

Miscellaneous

• Outstanding Shares: 102,850,000
• Free Float: 18,821,000
• Market Cap: $440.20 million
• Optionable: N/A
• Beta: 0.63